Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.
about
Human papillomavirus in high-grade cervical lesions: Austrian data of a European multicentre study.Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer.Reducing HPV-associated cancer globally.Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland.Effect of human papillomavirus vaccination on cervical cancer screening in Alberta.Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study.Cervical cancer: A comprehensive approach towards extermination.Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.Predictive value of negative cone margin status for risk of residual disease among women with cervical adenocarcinoma in situ.The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis.[Researcher of the month, October 2012].Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis.
P2860
Q30667372-89DBC763-7B91-4273-B388-19DC298DBAB5Q33589259-98D30EE4-7F52-42D8-8DE0-5E96F59831DDQ34244580-7040A1DF-B3FF-4D5E-A925-91AA12329342Q36022389-7CA88DAE-0644-4DAA-A418-C496DE00252FQ37227066-F94B743B-0685-4B6A-ABE7-346C1AC263A5Q37279345-5D681D5D-CF7E-447C-A1D1-8B2393B30871Q38748682-0FC085D4-1E22-4C8B-B586-913E7C38CB99Q39281387-940C15DA-6A5F-4841-AFAA-520B70756653Q46031371-007F62F2-C135-45C9-B9C7-F38DD3761874Q50042026-1ABB7A5D-B2A3-42EA-BCC4-873057E8E187Q52340945-C04C83E3-EC46-492E-93D4-5E8E0EAB1FB9Q54974379-C20EEE25-7B8D-4506-9BDC-BCDC89E7ABDE
P2860
Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Adenocarcinoma in situ and ass ...... human papillomavirus vaccine.
@en
Adenocarcinoma in situ and ass ...... human papillomavirus vaccine.
@nl
type
label
Adenocarcinoma in situ and ass ...... human papillomavirus vaccine.
@en
Adenocarcinoma in situ and ass ...... human papillomavirus vaccine.
@nl
prefLabel
Adenocarcinoma in situ and ass ...... human papillomavirus vaccine.
@en
Adenocarcinoma in situ and ass ...... human papillomavirus vaccine.
@nl
P2093
P2860
P50
P356
P1476
Adenocarcinoma in situ and ass ...... human papillomavirus vaccine.
@en
P2093
Daron G Ferris
Darron R Brown
Elizabeth I O Garner
Elmar A Joura
F Xavier Bosch
FUTURE I and II Study Group
Gonzalo Perez
Grace W K Tang
Heather L Sings
Kathy Harkins
P2860
P304
P356
10.1002/IJC.25723
P577
2011-01-12T00:00:00Z